This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
W.R. Berkley's (WRB) Q4 Earnings Beat on Higher Premiums
by Zacks Equity Research
W.R. Berkley's (WRB) Q4 results reflect higher premiums, a rise in the core portfolio, increased underwriting income and an improvement in the loss ratio.
The Zacks Analyst Blog Highlights Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson
by Zacks Equity Research
Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson are included in this Analyst Blog.
Top Research Reports for Novartis, Amgen & Palo Alto Networks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Amgen Inc. (AMGN) and Palo Alto Networks, Inc. (PANW).
Progressive's (PGR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Progressive's (PGR) fourth-quarter 2023 results reflect year-over-year improvement in the top line.
Brown & Brown's (BRO) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Brown & Brown's (BRO) Q4 results reflect strong organic growth, improved EBITDAC margin and higher net investment income, as well as lower expenses.
Here's What Key Metrics Tell Us About Brown & Brown (BRO) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Brown & Brown (BRO) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Arthur J. Gallagher (AJG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insights Into Brown & Brown (BRO) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Brown & Brown (BRO) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Arthur J. Gallagher (AJG) Buys MGB, Boosts Medical Reinsurance
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of MGB is set to enhance the growth of its medical reinsurance business and expand service offerings.
Marsh & McLennan (MMC) Up 14% in a Year: Upside Potential Left?
by Zacks Equity Research
Growth in the Latin America and Asia regions is expected to buoy Marsh & McLennan's (MMC) results.
Brown & Brown (BRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brown & Brown (BRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Bet on Brown & Brown (BRO) Now
by Zacks Equity Research
Brown & Brown (BRO) stands to gain from robust new businesses, premium rate increases across the majority of business lines, expansion initiatives, strategic buyouts and a strong financial position.
Arthur J. Gallagher (AJG) Adds Koberich to its Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Koberich is set to help it consolidate its presence in Europe.
Here's Why Hold Strategy is Apt for Willis Towers (WTW) Now
by Zacks Equity Research
Willis Towers (WTW) stands to gain from growth across the global lines of business, strategic inorganic expansion, higher demand for products and advisory work and a solid balance sheet.
Arthur J Gallagher (AJG) Rises 20% in a Year: More Upside Left?
by Zacks Equity Research
Arthur J Gallagher (AJG) is poised to grow from solid performance of the Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Travelers (TRV) Boosts Cyber Capabilities With Corvus Buyout
by Zacks Equity Research
Travelers (TRV) buyout of Corvus Insurance marks its step toward enhancing its cyber capabilities, a part of its strategic growth roadmap.
Here's Why Prudent Investors are Retaining AON Shares Now
by Zacks Equity Research
We expect AON's Reinsurance Solutions and Health Solutions businesses to play significant roles in top-line growth.
Is Bay Commercial Bank (BCML) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Bay Commercial Bank (BCML) and Brown & Brown (BRO) have performed compared to their sector so far this year.
Brown & Brown (BRO) Expands in Florida With Caton-Hosey Buyout
by Zacks Equity Research
Brown & Brown (BRO) signs an agreement to acquire Caton-Hosey, boosting its presence in Florida.
AIG Rises 9.6% in Three Months: What Lies Ahead for Investors?
by Zacks Equity Research
American International (AIG) continues to streamline its operations by axing non-core businesses, focusing on core insurance to improve profitability.
Why You Should Add RenaissanceRe (RNR) Stock to Your Portfolio
by Zacks Equity Research
An improvement in the top line led by higher premiums and net investment income poises RenaissanceRe (RNR) well for growth.
Here's Why You Should Add Aflac (AFL) to Your Portfolio
by Zacks Equity Research
Higher net investment income, lower expenses and improved profit levels from the U.S. business aid Aflac (AFL) well for growth.
Why CNO Financial (CNO) Deserves a Spot in Your Portfolio
by Zacks Equity Research
CNO Financial's (CNO) sustained growth in insurance policy income serves as a significant positive momentum for the company.
Analyzing AON's $13.4B NFP Acquisition Deal, Stock Declines
by Zacks Equity Research
AON expects more than $60 million in cost synergies from the NFP acquisition deal.
HCI Group (HCI) Affiliate TypTap Surpasses $1B In-Force Premium
by Zacks Equity Research
HCI Group's (HCI) TypTap assumes around 6,800 policies from the first transfer from Florida's Citizens Property Insurance Corporation.